Hangzhou, China

Junli He

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Innovations by Junli He in Nucleic Acid Detection

Introduction

Junli He is an accomplished inventor based in Hangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid detection. His innovative work has led to the development of advanced detection methods and reagent tubes that enhance the efficiency of nucleic acid extraction and analysis.

Latest Patents

Junli He holds 2 patents related to nucleic acid detection technologies. His first patent describes a nucleic acid integrated detection reagent tube. This invention includes a main tube and one or more branch tubes, featuring a lysing zone, a cleaning zone, and multiple separation plugs. The design allows for the effective separation of different zones and facilitates the magnetic transport of nucleic acids through hydrophobic layers. His second patent outlines a nucleic acid integrated detection method and reagent tube. This method involves separating lysis, cleaning, and reaction solutions within a detection reagent tube, enabling streamlined nucleic acid extraction, cleaning, and amplification reactions.

Career Highlights

Junli He is currently employed at Ustar Biotechnologies (Hangzhou) Ltd. His work at this company focuses on developing innovative solutions for nucleic acid detection, contributing to advancements in biotechnology and diagnostics.

Collaborations

Junli He collaborates with notable colleagues, including Qimin You and Lin Hu, who is a woman. These collaborations enhance the research and development efforts at Ustar Biotechnologies, fostering a dynamic environment for innovation.

Conclusion

Junli He’s contributions to nucleic acid detection technologies exemplify the impact of innovative thinking in biotechnology. His patents and work at Ustar Biotechnologies continue to advance the field, paving the way for more efficient diagnostic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…